CIK 0001819411
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Gain Therapeutics, Inc.
Sign in to watch- Ticker
- GANX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851726310
- Phone
- +1 301-500-1556
- Business address
- 4800 HAMPDEN LANE, SUITE 200, BETHESDA, MD, 20814
- 8-K Event Other events
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Material agreement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Delisting notice
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Shareholder vote results
- 8-K Event Material agreement · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change · Regulation FD disclosure
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 8-K Event Agreement ended
- 10-Q Report Quarterly Report
Page 3 of 5 · 92 filings